Research On Salary Incentive Plan For Research Team Of Generic Drugs In DS Group

With the deepening of national health care reform, the period of consolidation for pharmaceutical industry has arrived. If the pharmaceutical companies are willing to stand out of the competition, more attention must be paid to pharmaceutical research and development. That is to say that pharmaceutical company must attach importance to the management of scientific research team, stimulate the potential of scientific research staff and develop their innovation ability.Meanwhile, the development of domestic generic drugs has fallen behind. Besides, there is bare study about the management of generic R&D project and the incentive compensation in multi- project management. The 100 projects of DS Group have been in trouble due to the low enthusiasm caused by salary incentive problems. Therefore, the theoretical and practical significance must be paid to the study incentive compensation of generic drug R&D project team in domestic pharmaceutical companies.This paper, first of all, on the analysis of incentive compensation, features of knowledge-based workers and multi-program management study, summarizes the researcher feature and the current generic research proposes to establish the scientific incentive compensation plan of strengthen the generic research management and improve research efficiency. The features of “Profession, Large investment, Long-cycle, High risk” of generic drugs research, require personal ability and project difficulty in incentive compensation of researchers.Secondly, this paper has to be closely related the current situation of human resources and project development by using studies of qualitative and quantitative analysis methods and identifies the problems through interviews and satisfaction survey. In order to adjust the R&D incentive compensation plan, this paper has combined with the operating feature of generic drugs R&D and the development status of R&D, and adopted the mode of broadband salary.Establishing the difficulty assessment system for generic drug project, linking the difficulty and bonus of generic drug project and designing equity incentive program for the core talents who set up small R&D companies help to solve the problem of resource allocation in multi-project condition through factor analysis. Personalized flexible benefits system provides a powerful complement for incentive compensation. In order to ensure the smooth implementation of the incentive compensation plan, the companies should take all-round measures including propaganda training, system perfection. This program not only focuses on individual ability but also focuses on team performance. It is a comprehensive incentive compensation program of combining personal emoluments and team salary, which has strong practicability and maneuverability. For the other domestic generic drug companies, it may have the referenced value.